Bonus Biogroup Ltd. is a biotechnology company, which engages in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
Bonus Biogroup Ltd 주요 수익원은 Carpooling, Airport Pick-up and Drop-off, and Personal Drivers Services이며, 최신 수익 발표에서 수익은 177,570입니다. 지역별로는 China이 Bonus Biogroup Ltd의 주요 시장이며, 수익은 177,570입니다.
Bonus Biogroup Ltd은 수익성이 있나요?
no, 최신 재무제표에 따르면 Bonus Biogroup Ltd의 순손실은 $-27입니다.